
Amneal Pharmaceuticals, Inc.
AMRXHealthcare|Drug Manufacturers - Specialty & Generic|US
$20.14
+0.69 (+3.55%)
DCF Value
$14.00
Graham Number
$3.96
Cash / Share
$0.47
Next Earnings Report
Feb 26, 2027
EPS est. $0.24 · Revenue est. $834.5M
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Sep 3, 2026 (S-3ASR). Possible dilution.
Upcoming Data Readouts (3)
Feb 2027
Est. completion
Mar 2027
Est. completion
P3Male Hypogonadism
Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With Hypogonadism
NCT07898072n=190
Jan 2099
Est. completion
HIV Infections
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT00404989n=24,258
Recent Press Releases
Amneal Reports Third Quarter 2026 Financial Results
Nov 3, 2026 · GlobeNewsWire
Amneal to Report Third Quarter 2026 Results on November 3, 2026
Oct 8, 2026 · GlobeNewsWire
Amneal Announces FDA Approval and Launch of Lanreotide Injection
Sep 18, 2026 · GlobeNewsWire
STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm
Aug 19, 2026 · Business Wire
Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader
Aug 10, 2026 · GlobeNewsWire
SEC Filings (64)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 3, 2026 | 8-K | Material event | DocumentIndex |
| Oct 23, 2026 | 8-K/A | Material event | DocumentIndex |
| Sep 3, 2026 | S-3ASR | Shelf registration | DocumentIndex |
| Aug 12, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 12, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 12, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 10, 2026 | 8-K | Material event | DocumentIndex |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 3, 2026 | 8-K | Material event | DocumentIndex |
| Jul 31, 2026 | 8-K | Material event | DocumentIndex |
| Jul 30, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jul 30, 2026 | 8-K | Material event | DocumentIndex |
| Jun 29, 2026 | DEFM14A | Proxy / shareholder vote | DocumentIndex |
| Jun 18, 2026 | PREM14A | DocumentIndex | |
| May 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| Apr 27, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Apr 23, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 22, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 22, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 22, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 22, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 22, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 22, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 22, 2026 | 8-K | Material event | DocumentIndex |
| Mar 26, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Mar 26, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Mar 25, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Mar 25, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Feb 27, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 27, 2026 | 8-K | Material event | DocumentIndex |
| Feb 3, 2026 | 8-K | Material event | DocumentIndex |
| Jan 28, 2026 | 8-K | Material event | DocumentIndex |
| Jan 13, 2026 | 8-K | Material event | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 30, 2025 | 8-K | Material event | DocumentIndex |
| Oct 7, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 6, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 8, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |